Pharma 4.0 Market with COVID-19 Impact Analysis, By Technology (Cloud Computing, Artificial Intelligence, Big Data Analytics, Internet of Things), By Application (Drug Discovery and Development, Clinical Trials, Manufacturing), By End-User (Pharmaceutical Companies, Biotechnology Companies, CROs and CMOs), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Pharma 4.0 Market size was valued at USD 10,900 Million in 2022, expanding at a CAGR of 17.7% from 2023 to 2030.
The integration of modern digital technology, data analytics, robotics, and artificial intelligence into the pharmaceutical sector is referred to as Pharma 4.0, a notion based in the fourth industrial revolution. It intends to transform drug research, development, manufacturing, and treatment for patients by increasing operational efficiency, speeding innovation, optimizing supply chains, and allowing personalized medicine. Pharma 4.0 seeks to streamline processes, enhance product quality, and allow agile decision-making through real-time data-driven insights, predictive modeling, and interconnected smart systems, eventually leading to more patient-centric and sustainable healthcare the environment that embraces innovations in technology to address the evolving obstacles and possibilities within the pharmaceutical landscape.
Pharma 4.0 Market- Market Dynamics
- increasing pressure to accelerate drug development and bring new therapies to propel market demand
The pharmaceutical sector is facing increasing hurdles in treating complex illnesses and serving patient requirements in a timely manner. Pharma 4.0 allows more effective drug development procedures, predictive modeling for clinical trials, and optimized production by integrating sophisticated technologies such as artificial intelligence, machine learning, as well as information analytics. This not only saves time and money, but also improves the industry\'s agility in reacting to emergent health emergencies, regulatory changes, and consumer demands, resulting in speedier innovation and better access to breakthrough and life-saving therapies for patients.
Pharma 4.0 Market- Key Insights
- As per the analysis shared by our research analyst, the global Pharma 4.0 market is estimated to grow annually at a CAGR of around 17.7% over the forecast period (2023-2030)
- The Pharma 4.0 industry is projected to grow at a significant rate due to the increasing pressure to accelerate drug development and bring new therapies
- Based on Technology segmentation, Artificial Intelligence was predicted to show maximum market share in the year 2022
- Based on application segmentation, Clinical Trials was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Pharma 4.0 Market- Segmentation Analysis:
The Global Pharma 4.0 Market is segmented on the basis of Technology, Application, End-User, and Region.
The market is divided into three categories based on Technology: Cloud Computing, Artificial Intelligence, Big Data Analytics, Internet of Things. The Artificial Intelligence sector dominates the market. Pharma 4.0 employs artificial intelligence (AI) to transform the pharmaceutical sector. Complex data is analyzed by AI-powered algorithms, which speed up drug research, predict clinical trial results, and optimize production. This AI-Pharma 4.0 synergy improves decision-making, inventiveness, and patient-centered methods, resulting in a more productive and responsive healthcare environment.
The market is divided into three categories based on application: Drug Discovery and Development, Clinical Trials, Manufacturing. The Clinical Trials dominates the market and is likely to maintain its dominance during the forecast period. Clinical trials in Pharma 4.0 benefit from modern technology and data-driven techniques. Real-time data collecting, predictive modelling, and AI-powered patient recruiting all help to speed up trial design, patient monitoring, and outcome analysis. This integration improves trial efficiency, lowers costs, and speeds up the development and approval of novel medicines.
Pharma 4.0 Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several reasons are driving demand for Pharma 4.0 technologies in the Asia-Pacific region. The rapidly expanding pharmaceutical and biotechnology businesses in the area are attempting to use digital technologies to improve medication research, production efficiency, and patient care. With a large population, a variety of healthcare concerns, and rising healthcare costs, there is an urgent need to optimize procedures, expedite innovation, and enhance treatment results. Adopting Pharma 4.0 concepts has the ability to alleviate these issues by allowing for data-driven decision-making, personalized treatment methods, and simplified supply chains. The region\'s rapid economic development and technological improvements stimulate demand for novel pharmaceutical solutions.
Pharma 4.0 Market- Competitive Landscape:
Pharma 4.0\'s competitive environment includes both traditional pharmaceutical behemoths and creative startups. Pfizer, Novartis, and Roche are among the industry heavyweights investing in the digital shift to improve medication research, development, and production. Niche players and tech businesses specializing in AI, data analytics, and automation are joining the fray, bringing revolutionary solutions with them. Pharmaceutical companies and technology suppliers are collaborating and partnering to drive innovation. In the growing Pharma 4.0 market, competition is focused on establishing strong data platforms, powerful analytics, and flexible manufacturing systems to obtain a competitive advantage in expediting drug discovery, optimizing supply chains, and providing personalized healthcare solutions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PHARMA 4.0 MARKET KEY PLAYERS
- Pfizer Inc.
- Roche Holding AG
- Novartis AG
- Johnson & Johnson
- GlaxoSmithKline plc
- Sanofi S.A.
- AstraZeneca plc
- Merck & Co., Inc.
- Eli Lilly and Company
- AbbVie Inc.
- Boehringer Ingelheim International GmbH
- Takeda Pharmaceutical Company Limited
- Bristol Myers Squibb Company
- Moderna, Inc.
- Regeneron Pharmaceuticals, Inc.
GLOBAL PHARMA 4.0 MARKET, BY TECHNOLOGY
- Cloud Computing
- Artificial Intelligence
- Big Data Analytics
- Internet of Things
GLOBAL PHARMA 4.0 MARKET, BY APPLICATION
- Drug Discovery and Development
- Clinical Trials
- Manufacturing
GLOBAL PHARMA 4.0 MARKET, BY END-USER
- Pharmaceutical Companies
- Biotechnology Companies
- CROs and CMOs
GLOBAL PHARMA 4.0 MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Pharma 4.0 Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Pharma 4.0 Market Snippet by Technology
2.1.2. Pharma 4.0 Market Snippet by Application
2.1.3. Pharma 4.0 Market Snippet by End-User
2.1.4. Pharma 4.0 Market Snippet by Country
2.1.5. Pharma 4.0 Market Snippet by Region
2.2. Competitive Insights
3. Pharma 4.0 Key Market Trends
3.1. Pharma 4.0 Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Pharma 4.0 Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Pharma 4.0 Market Opportunities
3.4. Pharma 4.0 Market Future Trends
4. Pharma 4.0 Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Pharma 4.0 Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Pharma 4.0 Market Landscape
6.1. Pharma 4.0 Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Pharma 4.0 Market – By Technology
7.1. Overview
7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
7.1.2. Cloud Computing
7.1.3. Artificial Intelligence
7.1.4. Big Data Analytics
7.1.5. Internet of Things
8. Pharma 4.0 Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
8.1.2. Drug Discovery and Development
8.1.3. Clinical Trials
8.1.4. Manufacturing
9. Pharma 4.0 Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
9.1.2. Pharmaceutical Companies
9.1.3. Biotechnology Companies
9.1.4. CROs and CMOs
10. Pharma 4.0 Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Pharma 4.0 Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Pharma 4.0 Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Pharma 4.0 Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Pharma 4.0 Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Pharma 4.0 Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Pharma 4.0 Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Pfizer Inc.
11.2.2. Roche Holding AG
11.2.3. Novartis AG
11.2.4. Johnson & Johnson
11.2.5. GlaxoSmithKline plc
11.2.6. Sanofi S.A.
11.2.7. AstraZeneca plc
11.2.8. Merck & Co., Inc.
11.2.9. Eli Lilly and Company
11.2.10. AbbVie Inc.
11.2.11. Boehringer Ingelheim International GmbH
11.2.12. Takeda Pharmaceutical Company Limited
11.2.13. Bristol Myers Squibb Company
11.2.14. Moderna, Inc.
11.2.15. Regeneron Pharmaceuticals, Inc.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
